Trademarkia Logo

Canada

C$
PROSTAVISION
REGISTERED

on 1 Nov 2023

Last Applicant/ Owned by

ABX ADVANCED BIOCHEMICAL COMPOUNDS - BIOMEDIZINISCHE FORSCHUNGSREAGENZIEN GMBH

Heinrich-Gläser-Straße 10-1401454 Radeberg

DE

Serial Number

2150983 filed on 26th Jul 2021

Registration Number

TMA1206289 registered on 1st Nov 2023

Registration expiry Date

26th Jul 2031

Correspondent Address

LOUIS MARTINEAU

(MARTINEAU IP)1440 STE-CATHERINE OUESTSUITE 330MONTREAL

QUÉBEC

CA

H3G1R8

PROSTAVISION

Trademark usage description

pharmaceutical and veterinary products for the diagnosis of diseases of the prostate; pharmaceutical and veterinary products for the treatment of dise Read More

Classification Information


Class [005]
Pharmaceutical and veterinary products for the diagnosis of diseases of the prostate; pharmaceutical and veterinary products for the treatment of diseases of the prostate; pharmaceutical and veterinary products for the diagnosis of cancer; pharmaceutical and veterinary products for the treatment of cancer; medical and veterinary preparations for the diagnosis of diseases of the prostate; medical and veterinary preparations for the treatment of diseases of the prostate; medical and veterinary preparations for the diagnosis of cancer; medical and veterinary preparations for the treatment of cancer; dietetic foods and products for medical or veterinary purposes for the diagnosis of diseases of the prostate, containing a radiopharmaceutical compound; dietetic foods and products for medical or veterinary purposes for the treatment of diseases of the prostate, containing a radiopharmaceutical compound; dietetic foods and products for medical or veterinary purposes for the diagnosis of cancer, containing a radiopharmaceutical compound; dietetic foods and products for medical or veterinary purposes for the treatment of cancer, containing a radiopharmaceutical compound; nutritional supplements for the diagnosis of diseases of the prostate; nutritional supplements for the treatment of diseases of the prostate; nutritional supplements for the diagnosis of cancer; nutritional supplements for treating cancer; chemical preparations for medical or pharmaceutical purposes for the diagnosis of diseases of the prostate, containing a radiopharmaceutical compound; chemical preparations for medical or pharmaceutical purposes for the treatment of diseases of the prostate, containing a radiopharmaceutical compound; chemical preparations for medical or pharmaceutical purposes for the diagnosis of cancer, containing a radiopharmaceutical compound; chemical preparations for medical or pharmaceutical purposes for the treatment of cancer, containing a radiopharmaceutical compound; biological preparations for medical or pharmaceutical purposes for the diagnosis of diseases of the prostate, containing a radiopharmaceutical compound; biological preparations for medical or pharmaceutical purposes for the treatment of diseases of the prostate, containing a radiopharmaceutical compound; biological preparations for medical or pharmaceutical purposes for the diagnosis of cancer, containing a radiopharmaceutical compound; biological preparations for medical or pharmaceutical purposes for the treatment of cancer, containing a radiopharmaceutical compound; preparations for use in medical diagnostic processes relating to the diagnosis of diseases of the prostate; preparations for use in medical diagnostic processes relating to the diagnosis of cancer; diagnostic preparations and materials for use in medical diagnostic processes relating to the diagnosis of diseases of the prostate; diagnostic preparations and materials for use in medical diagnostic processes relating to the diagnosis of cancer.


Classification kind code

11

Mark Details


Serial Number

2150983

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 17th Feb 2023
Search Recorded
Submitted for opposition 20
on 17th Feb 2023
Examiner's First Report
Submitted for opposition 256
on 3rd Oct 2022
Notification of Possible Opposition Sent
Submitted for opposition 210
on 7th Jul 2022
IR Correction
Submitted for opposition 257
on 7th Jul 2022
Designation Notification - Madrid Protocol
Submitted for opposition 257
on 2th Dec 2021
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 1st Dec 2021
Formalized
Submitted for opposition 1
on 1st Dec 2021
Created
Submitted for opposition 228
on 26th Jul 2021
International Registration
Submitted for opposition 30
on 26th Jul 2021
Filed